Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pompe disease
Biotech
Sanofi CEO does not rule out future Pompe BD despite FTC moves
Sanofi CEO Paul Hudson said the company's M&A and business development strategy remains focused on the best science, despite recent FTC moves.
Max Bayer
Jan 10, 2024 3:37pm
Sanofi scraps Maze deal after FTC throws up antitrust obstacles
Dec 12, 2023 6:00am
Sanofi to enter Maze deal with $750M pact for Pompe med
May 1, 2023 6:00am
FDA lifts clinical hold on Astellas Pompe gene therapy
Jan 20, 2023 6:50am
Astellas' Pompe disease gene therapy placed on hold by FDA
Jun 27, 2022 9:03am
After phase 3 fumble, Amicus' Pompe disease drug hits new delay
May 11, 2022 10:20am